WO2000005205A1 - Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers - Google Patents
Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers Download PDFInfo
- Publication number
- WO2000005205A1 WO2000005205A1 PCT/IB1999/001296 IB9901296W WO0005205A1 WO 2000005205 A1 WO2000005205 A1 WO 2000005205A1 IB 9901296 W IB9901296 W IB 9901296W WO 0005205 A1 WO0005205 A1 WO 0005205A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- piperazin
- formula
- propane
- hydrochloride salt
- Prior art date
Links
- 0 CC(*)C(NC(*(C)C)=*)=* Chemical compound CC(*)C(NC(*(C)C)=*)=* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
- C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99929633A EP1097134A1 (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers |
NZ509388A NZ509388A (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers |
JP2000561162A JP2002521362A (en) | 1999-01-26 | 1999-07-16 | Allylpiperazine derivatives useful as uroselective α1-adrenoceptor blockers |
SK93-2001A SK932001A3 (en) | 1998-07-21 | 1999-07-16 | ARYLPIPERAZINE DERIVATIVES USEFUL AS UROSELECTIVEì (54) ALPHA1-ADRENOCEPTOR BLOCKERS |
PL99345562A PL345562A1 (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers |
AU46410/99A AU763541B2 (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers |
MXPA01000637A MXPA01000637A (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers. |
CA002338317A CA2338317A1 (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers |
HU0102980A HUP0102980A3 (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers, pharmaceutical compositions containing them and their use |
BR9912318-5A BR9912318A (en) | 1998-07-21 | 1999-07-16 | Compounds of 1- (4-arylpiperazin-1-yl) -w- [n- (ol, w -dicarboxymido)] alkanes of utility as uro-selective blockers of 1 - adrenoceptor. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/120,265 | 1998-07-21 | ||
US09/120,265 US6083950A (en) | 1997-11-13 | 1998-07-21 | 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers |
PCT/IB1999/000140 WO2000005206A1 (en) | 1998-07-21 | 1999-01-26 | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
IBPCT/IB99/00140 | 1999-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000005205A1 true WO2000005205A1 (en) | 2000-02-03 |
Family
ID=26318738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/001296 WO2000005205A1 (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1097134A1 (en) |
AU (1) | AU763541B2 (en) |
BR (1) | BR9912318A (en) |
CA (1) | CA2338317A1 (en) |
HU (1) | HUP0102980A3 (en) |
MX (1) | MXPA01000637A (en) |
NZ (1) | NZ509388A (en) |
PL (1) | PL345562A1 (en) |
SK (1) | SK932001A3 (en) |
WO (1) | WO2000005205A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005113498A1 (en) * | 2004-05-19 | 2005-12-01 | Ranbaxy Laboratories Limited | Adrenergic receptor antagonists |
WO2005118537A2 (en) * | 2004-05-31 | 2005-12-15 | Ranbaxy Laboratories Limited | Arylpiperazine derivatives as adrenergic receptor antagonists |
US9273120B2 (en) | 2001-03-27 | 2016-03-01 | Samuel Bogoch | Anthrax and small pox replikins and methods of use |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2242382A1 (en) * | 1971-09-04 | 1973-03-15 | Pfizer | NEW PIPERAZINE COMPOUNDS |
EP0000220A1 (en) * | 1977-06-18 | 1979-01-10 | Hoechst Aktiengesellschaft | Dihydrouracils, process for their preparation and pharmaceuticals containing them |
EP0103357A2 (en) * | 1982-06-22 | 1984-03-21 | Warner-Lambert Company | Substituted phenylpiperazine compounds suitable as antihypertensive agents, and processes for their production |
US4479954A (en) * | 1981-05-29 | 1984-10-30 | Eisai Co., Ltd. | Piperazine substituted carboxamide derivatives, compositions and method of use |
US4675403A (en) * | 1985-10-16 | 1987-06-23 | American Home Products Corporation | 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity |
EP0748800A2 (en) * | 1995-06-09 | 1996-12-18 | F. Hoffmann-La Roche Ag | Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists |
ES2094690A1 (en) * | 1994-11-22 | 1997-01-16 | Univ Madrid Complutense | New imido-piperazine derivatives |
-
1999
- 1999-07-16 NZ NZ509388A patent/NZ509388A/en unknown
- 1999-07-16 HU HU0102980A patent/HUP0102980A3/en unknown
- 1999-07-16 AU AU46410/99A patent/AU763541B2/en not_active Ceased
- 1999-07-16 PL PL99345562A patent/PL345562A1/en not_active Application Discontinuation
- 1999-07-16 WO PCT/IB1999/001296 patent/WO2000005205A1/en not_active Application Discontinuation
- 1999-07-16 SK SK93-2001A patent/SK932001A3/en unknown
- 1999-07-16 EP EP99929633A patent/EP1097134A1/en not_active Withdrawn
- 1999-07-16 BR BR9912318-5A patent/BR9912318A/en not_active IP Right Cessation
- 1999-07-16 CA CA002338317A patent/CA2338317A1/en not_active Abandoned
- 1999-07-16 MX MXPA01000637A patent/MXPA01000637A/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2242382A1 (en) * | 1971-09-04 | 1973-03-15 | Pfizer | NEW PIPERAZINE COMPOUNDS |
EP0000220A1 (en) * | 1977-06-18 | 1979-01-10 | Hoechst Aktiengesellschaft | Dihydrouracils, process for their preparation and pharmaceuticals containing them |
US4479954A (en) * | 1981-05-29 | 1984-10-30 | Eisai Co., Ltd. | Piperazine substituted carboxamide derivatives, compositions and method of use |
EP0103357A2 (en) * | 1982-06-22 | 1984-03-21 | Warner-Lambert Company | Substituted phenylpiperazine compounds suitable as antihypertensive agents, and processes for their production |
US4675403A (en) * | 1985-10-16 | 1987-06-23 | American Home Products Corporation | 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity |
ES2094690A1 (en) * | 1994-11-22 | 1997-01-16 | Univ Madrid Complutense | New imido-piperazine derivatives |
EP0748800A2 (en) * | 1995-06-09 | 1996-12-18 | F. Hoffmann-La Roche Ag | Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists |
Non-Patent Citations (23)
Title |
---|
ARCH. PHARM. (WEINHEIM, GER.) (1997), 330(5), 146-160 ;ISSN: 0365-6233, 1997 * |
ARCH. PHARM. (WEINHEIM, GER.) (1997), 330(6), 177-180 ;ISSN: 0365-6233 * |
B. KENNY ET AL: "Pharmacological Options in the Treatment of Benign Prostatic Hyperplasia", JOURNAL OF MEDICINAL CHEMISTRY., vol. 40, no. 9, 1997, WASHINGTON US, pages 1292 - 1315, XP002103453 * |
CHEMICAL ABSTRACTS, vol. 105, no. 19, 10 November 1986, Columbus, Ohio, US; abstract no. 164679, RYAN, M. J. ET AL: "CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4- imidazolinedione): antihypertensive profile and pharmacology" XP002103459 * |
CHEMICAL ABSTRACTS, vol. 107, no. 21, 23 November 1987, Columbus, Ohio, US; abstract no. 198046, KHADILKAR, B. M. ET AL: "Synthesis and pharmacology of some 2-[3-(4-aryl-1-piperazinyl)propyl]-1H- benz[de]isoquinolin-1,3(2H)-diones and -2,5-pyrrolidinediones" XP002103457 * |
CHEMICAL ABSTRACTS, vol. 108, no. 3, 18 January 1988, Columbus, Ohio, US; abstract no. 21844, HAYS, SHERYL J.: "Synthesis of carbon-14 labeled CI-926 and CI-927, new antihypertensives" XP002103461 * |
CHEMICAL ABSTRACTS, vol. 119, no. 3, 19 July 1993, Columbus, Ohio, US; abstract no. 27951, KHADILKAR, B. M. ET AL: "Synthesis and hypotensive activity of some succinimide derivatives" XP002103456 * |
CHEMICAL ABSTRACTS, vol. 127, no. 17, 27 October 1997, Columbus, Ohio, US; abstract no. 234308, CHILMONCZYK, ZDZISLAW ET AL: "Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore" XP002103460 * |
CHEMICAL ABSTRACTS, vol. 128, no. 1, 5 January 1998, Columbus, Ohio, US; abstract no. 128, MOKROSZ, MARIA J. ET AL: "Structure-activity relationship studies of CNS agents. Part 32. Effect o structural modifications in 1-arylpiperazine derivatives on.alpha.1-adrenoreceptor affinity" XP002103455 * |
CHEMICAL ABSTRACTS, vol. 129, no. 3, 20 July 1998, Columbus, Ohio, US; abstract no. 22916, DIMOGLO, A. S. ET AL: "Study of structure-activity relations in a series of buspirone analogs using an electron-topological approach" XP002103458 * |
DATABASE CHEMICAL ABSTRACTS Chemical Abstracts Service; XP002103462 * |
DATABASE CHEMICAL ABSTRACTS Chemical Abstracts Service; XP002103463 * |
DATABASE CHEMICAL ABSTRACTS Chemical Abstracts Service; XP002103464 * |
DATABASE CHEMICAL ABSTRACTS Chemical Abstracts Service; XP002103465 * |
INDIAN J. CHEM., SECT. B (1993), 32B(3), 338-42 ;ISSN: 0376-4699 * |
ISHIZUMI, KIKUO ET AL: "Synthesis and anxiolytic activity of N-substituted cyclic imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3- bicyclo[2.2.1]heptanedicarboximide (tandospirone) and related compounds", CHEM. PHARM. BULL. (1991), 39(9), 2288-300 ;ISSN: 0009-2363, 1991, XP002103452 * |
J. INDIAN CHEM. SOC. (1986), 63(5), 529-30 CODEN: JICSAH;ISSN: 0019-4522, 1986 * |
J. LABELLED COMPD. RADIOPHARM. (1987), 24(4), 351-60 ;ISSN: 0362-4803, 1987 * |
J. PHARMACOL. EXP. THER. (1986), 238(2), 473-9 ;ISSN: 0022-3565, 1986 * |
JERZY L MOKROSZ ET AL: "8-[4-[2-(1,2,3,4-tetrahydroisoquinolyl)butyl]-8-azaspiro[4,5]decane-7,9-dione: A new 5-HT1a receptor ligand with the same activity profile as buspirone", JOURNAL OF MEDICINAL CHEMISTRY, vol. 5, no. 39, 1 January 1996 (1996-01-01), pages 1125 1129, XP002074949 * |
KHIM.-FARM. ZH. (1998), 32(1), 36-40 ;ISSN: 0023-1134 * |
P.E. CROSS ET AL: "Substituted trifluoromethyl phenyl piperazines as anorectic agents", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.CHIMICA THERAPEUTICA., vol. 12, no. 2, 1977, PARIS FR, pages 173 - 176, XP002103454 * |
WU, YAO-HUA ET AL: "Psychosedative agents. N-(4-phenyl-1-piperazinylalkyl)-substituted cycli imides", J. MED. CHEM. (1969), 12, 876-81, 1969, XP002103451 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9273120B2 (en) | 2001-03-27 | 2016-03-01 | Samuel Bogoch | Anthrax and small pox replikins and methods of use |
WO2005113498A1 (en) * | 2004-05-19 | 2005-12-01 | Ranbaxy Laboratories Limited | Adrenergic receptor antagonists |
WO2005118537A2 (en) * | 2004-05-31 | 2005-12-15 | Ranbaxy Laboratories Limited | Arylpiperazine derivatives as adrenergic receptor antagonists |
WO2005118537A3 (en) * | 2004-05-31 | 2006-06-01 | Ranbaxy Lab Ltd | Arylpiperazine derivatives as adrenergic receptor antagonists |
Also Published As
Publication number | Publication date |
---|---|
EP1097134A1 (en) | 2001-05-09 |
NZ509388A (en) | 2003-12-19 |
PL345562A1 (en) | 2001-12-17 |
CA2338317A1 (en) | 2000-02-03 |
AU4641099A (en) | 2000-02-14 |
AU763541B2 (en) | 2003-07-24 |
HUP0102980A2 (en) | 2001-12-28 |
HUP0102980A3 (en) | 2003-02-28 |
MXPA01000637A (en) | 2002-04-08 |
BR9912318A (en) | 2001-05-02 |
SK932001A3 (en) | 2001-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6083950A (en) | 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers | |
US6914064B2 (en) | 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers | |
AU2002222315A1 (en) | 1,4-disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers | |
WO2000005206A1 (en) | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers | |
US6624314B2 (en) | Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action | |
AU763541B2 (en) | Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers | |
US6331623B1 (en) | Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action | |
US4677108A (en) | 4-oxo-pyrido[2,3-d]pyrimidinone derivatives | |
EP0915881B1 (en) | Pyrroloazepine compounds | |
TW562798B (en) | 1-(4-arylpiperazin-1-yl)-omega-[N-(alpha,omega-dicarboximido)]-alkanes useful as uroselective alpha1-adrenoceptor blockers and pharmaceutical compositions for treating benign prostatic hypertrophy in a mammal | |
JP2002521362A (en) | Allylpiperazine derivatives useful as uroselective α1-adrenoceptor blockers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99810842.1 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999929633 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 509388 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200100440 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017000736 Country of ref document: KR Ref document number: 46410/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2000 561162 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/000637 Country of ref document: MX Ref document number: 932001 Country of ref document: SK |
|
ENP | Entry into the national phase |
Ref document number: 2338317 Country of ref document: CA Ref document number: 2338317 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-235 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200100089 Country of ref document: VN |
|
WWP | Wipo information: published in national office |
Ref document number: 1999929633 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-235 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017000736 Country of ref document: KR |
|
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 03/2002 UNDER (30) REPLACE "NOT FURNISHED" BY "09/898151" |
|
WWG | Wipo information: grant in national office |
Ref document number: 46410/99 Country of ref document: AU |
|
WWR | Wipo information: refused in national office |
Ref document number: 1020017000736 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999929633 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-235 Country of ref document: CZ |